|
|
Post-herpetic Neuralgia
|
|
Post-herpetic Neuralgia
[an error occurred while processing this directive]
Depomed Announces Non-Binding Term Sheet Agreement With Biovail ... 24 Nov 2005
Canada. The company is also conducting a Phase II trial in post herpetic neuralgia with their product, Gabapentin GR. Additional ...
- Business Wire (press release),
Within the Herpes and Respiratory Antiviral Subcategory HSV/VZV ... Nov 21, 2005
However, clinical unmet needs mainly in CMV, VZV related post-herpetic neuralgia (PHN) and RSV maintain the call for new products. ...
- Business Wire (press release),
Data Reported From First Head-To-Head Study Evaluating Lidoderm(R) ... Nov 16, 2005
Lidoderm(R) is a topical analgesic patch approved to treat the pain of post-herpetic neuralgia, a chronic condition resulting from nerve damage caused by ...
- PR Newswire (press release),
Cita NeuroPharmaceuticals Inc. Accepts Offer by UK-Based Vernalis ... Nov 18, 2005
This type of pain occurs in the course of diabetes, post-herpetic neuralgia (shingles), the side effects of chemotherapy, trigeminal (facial) neuralgia, HIV ...
- PR Newswire (press release),
Endo's Lidoderm may compete for COX-2 void Nov 16, 2005
...she said. Currently, Lidoderm is only approved in the United States for the treatment of the pain of post-herpetic neuralgia. Also ...
- Science Daily (press release)
XenoPort to Present at the Lazard Capital Markets Life Science ... Nov 17, 2005
...a Phase 2b clinical trial for the treatment of restless legs syndrome, or RLS, and a Phase 2a clinical trial for the management of post-herpetic neuralgia. ...
- Yahoo! News (press release)
Depomed Completes Enrollment for Phase II Clinical Trial for ... Oct 24, 2005
Canada. The company is also conducting a Phase II trial in post herpetic neuralgia with their product, Gabapentin GR(TM). Additional ...
- Genetic Engineering News,
UCB Receives FDA Orphan Drug Designation for Brivaracetam for the ... Nov 8, 2005
...is currently being studied (Phase 2 clinical trials) in patients with refractory partial onset seizures and in patients with post-herpetic neuralgia. ...
- PrimeZone (press release),
UCB Receives FDA Orphan Drug Designation for Brivaracetam for the ... Nov 9, 2005
...is currently being studied (Phase 2 clinical trials) in patients with refractory partial onset seizures and in patients with post-herpetic neuralgia.
- Biotech Intelligence (press release),
Results Reported in Open-Label Pilot Study of Lidoderm(R) in ... Oct 27, 2005
...is a topical analgesic patch approved by the US Food and Drug Administration (FDA) in 1999 to treat the pain associated with post-herpetic neuralgia (PHN), a ...
- PR Newswire (press release),
Preventing chickenpox Nov 1, 2005
...particularly in older people. Post-herpetic neuralgia occurs in up to 50% of herpes zoster cases in the elderly. Although shingles can ...
- AustralianDoctor.com (subscription),
MEDIVIR, INTERIM REPORT, 1 January – 30 September 2005 Oct 26, 2005
...on the shingles indication suggests that valomaciclovir is more effective than current therapies for alleviating the PHN (post-herpetic neuralgia, or chronic ...
- Biotech Intelligence (press release),
Depomed Promotes Carl Pelzel to Executive Vice President, Chief ... Sep 27, 2005
Canada. The company is also conducting a Phase II trial in post herpetic neuralgia with their product, Gabapentin GR. Additional ...
- Business Wire (press release)
Health Watch: Shingles Vaccine Sep 19, 2005
Dr. Wendy Keitel-Immunologist: "And importantly, it reduced the occurrence of post-herpetic neuralgia or this prolonged pain syndrome by two-thirds in the ...
- KFOXtv.com
Vaccine prevents shingles Sep 4, 2005
...the antiviral drugs acyclovir and valaciclovir, which many people know as Valtrex, can shorten the illness and reduce the frequency of post-herpetic neuralgia. ...
- Staunton News Leader
Depomed to Present at the ThinkEquity Partners Growth Conference Sep 7, 2005
Canada. The company is also conducting a Phase II trial in post herpetic neuralgia with their product, Gabapentin GR(TM). Additional ...
- Genetic Engineering News
Eyes turning to neuropathic pain market Sep 16, 2005
Key sub-types of neuropathic pain include diabetic neuropathic pain (DNP), post-herpetic neuralgia (PHN) and HIV-associated neuropathic pain (HIVNP). ...
- Pharmaceutical Business Review
Pharmaceutical Public Education Grants AVailable Sep 1, 2005
Neurontin is a prescription medication approved by the US Food and Drug Administration for treatment of epilepsy and post-herpetic neuralgia. ...
- Community Dispatch (press release)
XenoPort Appoints Gary D. Tollefson, Former Lilly Executive, to ... Sep 6, 2005
...completed a Phase 2b clinical trial for the treatment of restless legs syndrome and a Phase 2a clinical trial for the management of post- herpetic neuralgia. ...
- Yahoo! News (press release)
Research and Markets: Pipeline Drugs Fail to Nail Neuropathic Pain Aug 30, 2005
...a neuropathic pain indication are included together with an investigation of the key neuropathic pain subtypes: post-herpetic neuralgia, diabetic neuropathic ...
- Business Wire (press release)
Warner-Lambert Settlement Funds Drug Education Program Aug 31, 2005
...medication approved by the Food and Drug Administration ("FDA") for assistance in the treatment of epilepsy and treatment of post-herpetic neuralgia. ...
- Empire Journal
Nerve pain responds to combination treatment Aug 30, 2005
...diabetic neuropathy, a complication of diabetes in which nerves are damaged as a result of high blood sugar, and post-herpetic neuralgia, the persistence of ...
- Macleans
What is the best treatment for postherpetic neuralgia31 Jul 2005
A systematic review of the evidence for the many drug treatments used in post herpetic neuralgia (the pain that persists after shingles) concludes that long ...
- I-Newswire.com
Old, new post-shingles medication workJul 26, 2005
Post herpetic neuralgia -- the pain that persists after shingles -- is one of a group of chronic pain conditions collectively called "neuropathic pain" and is ...
- Washington Times
Home > Spinifex secures $3.25m investment to develop pain therapyJul 26, 2005
...an estimated 45 per cent of diabetics, and through complications arising from infection with herpes zoster [shingles], known as post-herpetic neuralgia. ...
- I-Newswire.com
Neuropathic Pain Market to Reach $3.5 Billion by 2014, Despite ...Jul 11, 2005
...growth over the past two years has been driven largely by the approval of Neurontin's first neuropathic pain indication in the US, post-herpetic neuralgia. ...
- Yahoo News
XenoPort, Inc. to Release Second Quarter Financial Results on ...Jul 26, 2005
...a Phase 2b clinical trial for the treatment of restless legs syndrome and has completed a Phase 2a clinical trial for the management of post-herpetic neuralgia ...
- Forbes
Report describes Potential Problem With New Drug for Seizures ...Jul 23, 2005
...the experiences of an 80-year-old women who took pregabalin as part of a clinical trial of the drug for treatment of post-herpetic neuralgia, a painful ...
- eMaxHealth.com
Health Highlights: July 6, 2005Jul 6, 2005
And recently people have begun taking these drugs for other reasons, including the treatment of post-herpetic neuralgia, a painful condition that lingers after ...
- Atlanta Journal Constitution (subscription)
The Medical Minute: Shingles -- Good news about an old problemJul 20, 2005
...lasts years or decades. This chronic pain, termed "post-herpetic neuralgia" (PHN), can have a major impact on its victims. It can be ...
- Penn State Live
XenoPort stock surges on analyst reportJul 13, 2005
Harr noted the drug has completed positive Phase II trials for restless leg syndrome and post-herpetic neuralgia, "two large and under-treated markets," the ...
- BusinessWeek
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Post-herpetic Neuralgia
you may want to try searching the Internet using the Google search box below.
|
|
|
